Aphria Inc. (TSX: APH) (OTC: APHQF) recently announced that its Malta-based subsidiary, ASG Pharma (“ASG”), has received the first import license for medical cannabis issued by the Malta Medicines Authority. The license enables ASG, a high-capacity EU GMP-certified lab, to import medical cannabis for analytical testing and research. The receipt of the license marks a significant milestone for the company, positioning ASG at the forefront of testing, research and development of medical cannabis in Europe. “Our EU GMP-certified lab in Malta will not only be a leading European center for R&D and testing, but also will provide a gateway to medical cannabis markets across Europe,” Aphria CEO Vic Neufeld stated in the news release. “We continue to pursue the most attractive strategic opportunities for medical cannabis in Europe and around the world, and this initial license sets the stage for ASG’s long-term future as Aphria’s processing, manufacturing and distribution hub for the entire continent.”
To view the full press release, visit http://cnw.fm/B7Wti
About Aphria
Aphria is a global cannabis company driven by an unrelenting commitment to its people, product quality and innovation. Headquartered in Leamington, Ontario – the greenhouse capital of Canada – Aphria engages in low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Focusing on untapped opportunities and backed by the latest technologies, patents and IP, Aphria is committed to bringing breakthrough innovation to the global cannabis market. The company’s in-house and licensed portfolio of brands are grounded in expertly-researched consumer insights designed to meet the needs of every consumer segment. Rooted in its founders’ multi-generational expertise in commercial agriculture, Aphria drives sustainable long-term shareholder value through a diversified approach to innovation, strategic partnerships and global expansion, with a presence in over 10 countries across 5 continents. For more information, visit the company’s website at www.Aphria.ca.
More from CannabisNewsBreaks
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net